Since it was launched in 2006, the primary objective of the NevroNor initiative has been to provide support for Norwegian neuroscience research of top international calibre. To be eligible for funding under the initiative, research must be of relevance to human health and disease.
Norwegian researchers have mapped genetic variations associated with an increased risk of multiple sclerosis (MS) and myasthenia gravis (MG), bringing science one step closer to understanding these serious autoimmune disorders.
The Research Council of Norway is moving to a new location seven kilometres west of central Oslo, in Lysaker.
HBP has reserved a portion of its ramp-up phase funding for specific tasks to be carried out by new beneficiaries who will join the consortium in 2014. These new beneficiaries will be selected from proposals submitted in response to this Competitive Call. The proposals should encompass research activities exclusively.